Enzyme replacement therapy and beyond—in memoriam Roscoe O. Brady, M.D. (1923–2016)
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enzyme replacement therapy and beyond—in memoriam Roscoe O. Brady, M.D. (1923–2016)
Authors
Keywords
Rivaroxaban, Enzyme Replacement Therapy, Fabry Disease, Gauche Disease, Orphan Drug
Journal
JOURNAL OF INHERITED METABOLIC DISEASE
Volume 40, Issue 3, Pages 343-356
Publisher
Springer Nature
Online
2017-03-17
DOI
10.1007/s10545-017-0032-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase 1/2 study of intrathecal heparan-N-sulfatase in patients with mucopolysaccharidosis IIIA
- (2016) Simon A. Jones et al. MOLECULAR GENETICS AND METABOLISM
- Advocacy: Strong foundations
- (2016) James Mitchell Crow NATURE
- Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
- (2016) Dominique P. Germain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel Treatments for Rare Cancers: The U.S. Orphan Drug Act Is Delivering—A Cross-Sectional Analysis
- (2016) Clemens Stockklausner et al. ONCOLOGIST
- Fabry Disease: A Disorder of Childhood Onset
- (2016) Raphael Schiffmann et al. PEDIATRIC NEUROLOGY
- A phase I/II study of intrathecal idursulfase-IT in children with severe mucopolysaccharidosis II
- (2015) Joseph Muenzer et al. GENETICS IN MEDICINE
- Effect of Oral Eliglustat on Splenomegaly in Patients With Gaucher Disease Type 1
- (2015) Pramod K. Mistry et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A prospective 10-year study of individualized, intensified enzyme replacement therapy in advanced Fabry disease
- (2015) Raphael Schiffmann et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Eliglustat compared with imiglucerase in patients with Gaucher's disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trial
- (2015) Timothy M Cox et al. LANCET
- Pressure for drug development in lysosomal storage disorders – a quantitative analysis thirty years beyond the US orphan drug act
- (2015) Konstantin Mechler et al. Orphanet Journal of Rare Diseases
- Improvement of CNS Defects Via Continuous Intrathecal Enzyme Replacement by Osmotic Pump in Mucopolysaccharidosis Type II Mice
- (2013) Young Bae Sohn et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Insulin-like growth factor II peptide fusion enables uptake and lysosomal delivery of α-N-acetylglucosaminidase to mucopolysaccharidosis type IIIB fibroblasts
- (2013) Shih-hsin Kan et al. BIOCHEMICAL JOURNAL
- Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy
- (2013) Virginia Haurigot et al. JOURNAL OF CLINICAL INVESTIGATION
- Biochemical evidence of the effects of SBC-103, a recombinant human alpha-N-acetylglucosaminidase in a mucopolysaccharidosis IIIB mouse model using an improved analytical method for substrate quantification
- (2013) Mark Leavitt et al. MOLECULAR GENETICS AND METABOLISM
- High-dose enzyme replacement therapy in murine Hurler syndrome
- (2013) Li Ou et al. MOLECULAR GENETICS AND METABOLISM
- Pilot study using ambroxol as a pharmacological chaperone in type 1 Gaucher disease
- (2012) Ari Zimran et al. BLOOD CELLS MOLECULES AND DISEASES
- Intracerebroventricular Transplantation of Human Bone Marrow-Derived Multipotent Progenitor Cells in an Immunodeficient Mouse Model of Mucopolysaccharidosis Type I (MPS-I)
- (2012) Zhenhong Nan et al. CELL TRANSPLANTATION
- Gene Therapy for Mucopolysaccharidosis Type VI Is Effective in Cats Without Pre-Existing Immunity to AAV8
- (2012) Rita Ferla et al. HUMAN GENE THERAPY
- Glycosylation-independent Lysosomal Targeting of Acid α-Glucosidase Enhances Muscle Glycogen Clearance in Pompe Mice
- (2012) John A. Maga et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Safety and pharmacodynamic effects of a pharmacological chaperone on α-galactosidase A activity and globotriaosylceramide clearance in Fabry disease: report from two phase 2 clinical studies
- (2012) Dominique P Germain et al. Orphanet Journal of Rare Diseases
- CNS Penetration of Intrathecal-Lumbar Idursulfase in the Monkey, Dog and Mouse: Implications for Neurological Outcomes of Lysosomal Storage Disorder
- (2012) Pericles Calias et al. PLoS One
- The Pharmacological Chaperone AT2220 Increases Recombinant Human Acid α-Glucosidase Uptake and Glycogen Reduction in a Mouse Model of Pompe Disease
- (2012) Richie Khanna et al. PLoS One
- Strategies for Neoglycan Conjugation to Human Acid α-Glucosidase
- (2011) Qun Zhou et al. BIOCONJUGATE CHEMISTRY
- Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease
- (2011) A. Zimran et al. BLOOD
- Ex Vivoandin VivoEffects of Isofagomine on Acid β-Glucosidase Variants and Substrate Levels in Gaucher Disease
- (2011) Ying Sun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Limitations of drug registries to evaluate orphan medicinal products for the treatment of lysosomal storage disorders
- (2011) Carla EM Hollak et al. Orphanet Journal of Rare Diseases
- Safety Evaluation of Chronic Intrathecal Administration of Idursulfase-IT in Cynomolgus Monkeys
- (2011) Brian R. Felice et al. TOXICOLOGIC PATHOLOGY
- Assessment of neurological and behavioural function: the NIH Toolbox
- (2010) Richard C Gershon et al. LANCET NEUROLOGY
- An open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay–Sachs or Sandhoff variants)
- (2010) Joe T.R. Clarke et al. MOLECULAR GENETICS AND METABOLISM
- Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial
- (2009) S. Strothotte et al. JOURNAL OF NEUROLOGY
- Twice-Daily Cysteamine Bitartrate Therapy for Children with Cystinosis
- (2009) Ranjan Dohil et al. JOURNAL OF PEDIATRICS
- The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy
- (2009) Craig M. McDonald et al. MUSCLE & NERVE
- Chronic Cyclodextrin Treatment of Murine Niemann-Pick C Disease Ameliorates Neuronal Cholesterol and Glycosphingolipid Storage and Disease Progression
- (2009) Cristin D. Davidson et al. PLoS One
- Randomized, controlled trial of miglustat in Gaucher's disease type 3
- (2008) Raphael Schiffmann et al. ANNALS OF NEUROLOGY
- Reversal of peripheral and central neural storage and ataxia after recombinant enzyme replacement therapy in α-mannosidosis mice
- (2008) Judith Blanz et al. HUMAN MOLECULAR GENETICS
- Cognitive Outcome in Treated Patients with Chronic Neuronopathic Gaucher Disease
- (2008) Ozlem Goker-Alpan et al. JOURNAL OF PEDIATRICS
- Does orphan drug legislation really answer the needs of patients?
- (2008) Marlene E Haffner et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search